Pragmatic Clinical Trials in Neurology

Area of Science:

• Neurology
• Clinical Trials
• Health Services Research

Background:

• Increasing need for pragmatic clinical trials in neurological diseases.
• Multiple therapeutic interventions and complex treatment approaches necessitate comparative effectiveness research.
• Gaps exist between trial-specific and real-world patient outcomes.

Purpose of the Study:

• To review the designs and unique aspects of pragmatic clinical trials for neurological diseases.
• To highlight the suitability of pragmatic trials for real-world effectiveness evaluations.
• To discuss data collection strategies using electronic health records and registries.

Main Methods:

• Overview of various pragmatic trial designs: individual randomized trials, cluster-randomized trials (parallel, crossover), non-randomized trials, and prospective cohort studies.
• Discussion of specific design variations within cluster trials (unidirectional, bidirectional, alternating crossover).
• Exploration of data collection methods utilizing existing registries, electronic health records (EHRs), and claims data.

Main Results:

• Pragmatic trials offer diverse designs to suit different research questions in neurology.
• Leveraging existing data sources like EHRs and registries enhances feasibility and real-world applicability.
• These trials are well-suited for evaluating therapeutic interventions in broad, real-world neurological patient populations.

Conclusions:

• Pragmatic clinical trials are essential for advancing the evaluation of therapeutic interventions in neurological diseases.
• The adaptability of trial designs and data collection methods makes them ideal for real-world effectiveness studies.
• Future research should continue to refine and implement pragmatic trial methodologies in neurology.